Cargando…
Anti-Obesity Medication Use in Children and Adolescents with Prader–Willi Syndrome: Case Review and Literature Search
(1) Background: children with Prader-Willi syndrome (PWS) have high obesity rates due to hyperphagia and decreased metabolic rates. Although anti-obesity medications (AOMs) are prescribed to this population, there are no consensus guidelines on acceptability, safety, and efficacy. We present literat...
Autores principales: | Goldman, Victoria E., Naguib, Monica N., Vidmar, Alaina P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509766/ https://www.ncbi.nlm.nih.gov/pubmed/34640558 http://dx.doi.org/10.3390/jcm10194540 |
Ejemplares similares
-
Liraglutide for Weight Management in Children and Adolescents With Prader–Willi Syndrome and Obesity
por: Diene, Gwenaëlle, et al.
Publicado: (2022) -
French database of children and adolescents with Prader-Willi syndrome
por: Molinas, Catherine, et al.
Publicado: (2008) -
Dietary Management for Adolescents with Prader–Willi Syndrome
por: Miller, Jennifer L, et al.
Publicado: (2020) -
Nutritional intakes in children with Prader–Willi syndrome and non-congenital obesity
por: Rubin, Daniela A., et al.
Publicado: (2015) -
Alteration of brain nuclei in obese children with and without Prader-Willi syndrome
por: Wu, Ning, et al.
Publicado: (2022)